These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 20362649

  • 1. Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology.
    Zhao L, Gao Y, Yang Y, Wei Y, Li Y, Feng H, Wei W, Ding Y, Sun D.
    Toxicol Lett; 2010 Jun 02; 195(2-3):155-60. PubMed ID: 20362649
    [Abstract] [Full Text] [Related]

  • 2. Changes in serum thioredoxin among individuals chronically exposed to arsenic in drinking water.
    Li Y, Gao Y, Zhao L, Wei Y, Feng H, Wang C, Wei W, Ding Y, Sun D.
    Toxicol Appl Pharmacol; 2012 Feb 15; 259(1):124-32. PubMed ID: 22202168
    [Abstract] [Full Text] [Related]

  • 3. Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers.
    Zhai R, Su S, Lu X, Liao R, Ge X, He M, Huang Y, Mai S, Lu X, Christiani D.
    Biometals; 2005 Dec 15; 18(6):603-13. PubMed ID: 16388400
    [Abstract] [Full Text] [Related]

  • 4. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD, Wang DC, Zheng S, Fan ZM, Li JL, Feng CW, Zhang YR, Liu B, Gao SS, He X, Feng XS.
    Ai Zheng; 2006 May 15; 25(5):549-54. PubMed ID: 16687072
    [Abstract] [Full Text] [Related]

  • 5. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M, Zhang X, Hu Y, Wang H, He W, Mei H, Yu J, Guo T, Song S.
    Thromb Res; 2009 May 15; 123(3):556-64. PubMed ID: 18620739
    [Abstract] [Full Text] [Related]

  • 6. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.
    Jpn J Clin Oncol; 2010 Apr 15; 40(4):336-42. PubMed ID: 20089528
    [Abstract] [Full Text] [Related]

  • 7. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K.
    Cancer Res; 2006 Feb 01; 66(3):1844-50. PubMed ID: 16452246
    [Abstract] [Full Text] [Related]

  • 8. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L, Zhou L, Tao L, Zhang M, Cui JF, Liu YK.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2526-30. PubMed ID: 18067823
    [Abstract] [Full Text] [Related]

  • 9. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP, Shen J, Li ZF, Yan L, Gu J.
    Cancer Invest; 2006 Dec 25; 24(8):747-53. PubMed ID: 17162557
    [Abstract] [Full Text] [Related]

  • 10. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP.
    Arthritis Rheum; 2005 Dec 25; 52(12):3801-12. PubMed ID: 16320331
    [Abstract] [Full Text] [Related]

  • 11. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A.
    Rapid Commun Mass Spectrom; 2007 Dec 25; 21(24):4142-8. PubMed ID: 18022963
    [Abstract] [Full Text] [Related]

  • 12. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
    Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, Yang BX, He DC, Zhao XJ.
    Asian J Androl; 2006 Jan 25; 8(1):45-51. PubMed ID: 16372118
    [Abstract] [Full Text] [Related]

  • 13. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.
    Clin Invest Med; 2006 Jun 25; 29(3):136-45. PubMed ID: 17058431
    [Abstract] [Full Text] [Related]

  • 14. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.
    BMC Cancer; 2005 Jul 20; 5():83. PubMed ID: 16029516
    [Abstract] [Full Text] [Related]

  • 15. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX, Zhang B, Yu JK, Liu J, Yang MQ, Zheng S.
    Chin Med J (Engl); 2005 Aug 05; 118(15):1278-84. PubMed ID: 16117882
    [Abstract] [Full Text] [Related]

  • 16. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):45-53. PubMed ID: 17070117
    [Abstract] [Full Text] [Related]

  • 17. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ, Du J, Pang D.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 15; 28(3):204-7. PubMed ID: 16875606
    [Abstract] [Full Text] [Related]

  • 18. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG, Xia ZS, Han Y, French AM, O'Rourke AK, Terris DJ, Adam BL.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 15; 132(4):390-7. PubMed ID: 16618908
    [Abstract] [Full Text] [Related]

  • 19. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
    Fröbel J, Hartwig S, Passlack W, Eckel J, Haas R, Czibere A, Lehr S.
    Arch Physiol Biochem; 2010 Apr 15; 116(4-5):174-80. PubMed ID: 20662595
    [Abstract] [Full Text] [Related]

  • 20. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM, Pitts RL.
    Methods Mol Biol; 2008 Apr 15; 441():57-70. PubMed ID: 18370311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.